Sinocare Showcased New Diabetes Management Tools at EASD
The company demonstrated updated blood glucose and multifunction diagnostic systems for patients and clinicians.
Updated on Sept. 30, 2026 in Diabetes
Live Poll
Do you believe digital monitoring tools improve your ability to manage your chronic health conditions?
At the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan, Sinocare presented several new diagnostic technologies. These devices include systems designed for faster blood glucose monitoring and multifunction analysis for clinical use.
Why it matters
These tools aim to streamline chronic disease management by reducing the time required to obtain critical diagnostic data. For patients and providers, such advancements potentially simplify the regular monitoring necessary to manage blood glucose levels effectively.
Sinocare presented their portfolio at the 62nd Annual Meeting of the European Association for the Study of Diabetes, highlighting a blood glucose monitoring system that provides results in 5 seconds and a multifunction analyzer yielding results in 3 to 15 minutes.
The players
Sinocare
A global company established in 2002 that develops biosensing technologies and integrated healthcare solutions for diabetes management.
European Association for the Study of Diabetes
An international professional organization that hosts an annual meeting to share advancements in diabetes research and clinical care.
The details
The Safe AQ 8000 system is designed to integrate data from blood glucose meters and continuous glucose monitors through a centralized doctor web portal, facilitating better clinical oversight. Additionally, the company showcased the AGEscan detector, which utilizes non-invasive technology to identify Advanced Glycation End Products that can accumulate in the body as a result of chronic high blood sugar.
Timeline
Sinocare was established in 2002.
The EASD 2026 meeting began in Milan on September 28, 2026.
This report was published on September 30, 2026.
The EASD 2026 meeting concludes on October 2, 2026.
Health Landscape
The Sinocare presentation marks a continuation of the industry trend toward integrated digital health platforms showcased at the European Association for the Study of Diabetes annual meeting. It follows a pattern established by major diagnostic manufacturers using the meeting to debut faster sensing technologies.
If you are managing diabetes, these technological updates highlight the increasing availability of tools that combine blood glucose and continuous monitoring data. It is worth discussing with your doctor whether a centralized data-tracking system could simplify your regular health checkups.
The takeaway
Advancements in diagnostic speed and data integration are helping to modernize routine diabetes monitoring. Patients should focus on maintaining consistent tracking habits and discuss the latest digital monitoring options with their primary care physician.
Further reading
For more information on the latest innovations in glucose tracking, visit our Diabetes section.
More information
Review the latest corporate developments and product specifications on the Sinocare official company information portal.
Live Poll
Do you believe digital monitoring tools improve your ability to manage your chronic health conditions?
